In May, the U.S. Food and Drug Administration guaranteed an experimental autism drug a speedy review for approval, but some scientists are skeptical of the drug’s potential.

A huge new research collaboration may jump-start the race to develop therapies for autism.

Many clinics offer neurofeedback as a therapy for autism, despite little scientific support for the technique.

People with mutations in SHANK3 have milder features than do those missing a chunk of DNA that includes the gene.

Scientists release a list of all randomized controlled trials of autism treatments, China establishes a brain center for an ambitious new project, and people around the world march for science again.

Neuroscientists are sounding the alarm about ‘pseudoreplication,’ a widespread practice that studs the literature with false results.

A woman with autism had to fight for her sterilization surgery, a mother’s tactics with her son on the spectrum generate controversy, and gifted students with autism have unique struggles.

Folic acid, a B vitamin, may lower autism risk and ease features of the condition.

The U.S. Food and Drug Administration has granted a rare ‘breakthrough therapy’ designation for a drug that may ease some features of autism.